SEARCH ARTICLES
LATEST ARTICLES
Table of Contents
2018 Month : July Volume : 7 Issue : 30 Page : 3348-3351A COMPARATIVE ANALYSIS OF ACUTE TOXICITIES IN HYPOFRACTIONATED RADIOTHERAPY VERSUS CONVENTIONAL RADIOTHERAPY IN EARLY-STAGE BREAST CANCER AFTER BREAST CONSERVATION SURGERY.
Sukrutha Boggula1, Ashwini Gopal2, Suneetha Mulinti3, Alluri Krishnam Raju4
1Registrar, Department of Radiation Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.
2Registrar, Department of Radiation Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.
3Consultant Radiation Oncologist, Department of Radiation Oncology, Continental Hospital, Hyderabad, Telangana, India.
4Consultant Radiation Oncologist, Department of Radiation Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.
References :
Harsolia A, Kestin L, Grills I, et al. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 2007;68(5):1375-80.
CrossRef | Google Scholar | PubMedThe START Trialists’ Group, Bentzen SM, Agrawal RK, et al. The UK of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008;9(4):331-41.
CrossRef | Google Scholar | PubMedThe START Trialists’ Group, Bentzen SM, Agrawal RK, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008;371(9618):1098-107.
CrossRef | Google Scholar | PubMedBartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007;25(22):3259-65.
CrossRef | PubMedRomestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized trial in Lyon, France. J Clin Oncol 1997;15(3):963-8.
CrossRef | Google Scholar | PubMedWhelan TJ, Pignol JP, Levine MN, et al. Long-term result of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362:513-20.
CrossRef | Google Scholar |Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002;54(5):1336-44.
CrossRef | Google Scholar | PubMedFisher J, Scott C, Stevens R, et al. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000;48(5):1307-10.
CrossRef | Google Scholar | PubMedChen MF, Chen WC, Lai CH, et al. Predictive factors of radiation-induced skin toxicity in breast cancer patients. BMC Cancer 2010;10:508.
CrossRef | Google Scholar | PubMed